{"nctId":"NCT05097326","briefTitle":"Mifepristone for Labor Induction","startDateStruct":{"date":"2022-06-27","type":"ACTUAL"},"conditions":["Induced Vaginal Delivery"],"count":30,"armGroups":[{"label":"Mifepristone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Mifepristone"]},{"label":"Misoprostol","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Misoprostol"]}],"interventions":[{"name":"Mifepristone","otherNames":[]},{"name":"Misoprostol","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Pregnant patients between ages 18 to 45 years\n2. Singleton, live gestation\n3. Nulliparous\n4. Gestational age between 37 weeks 0 days - 42 weeks 0 days\n5. Fetus in cephalic presentation\n6. Patients admitted for labor induction\n7. Patients who are not in labor with intact membranes\n8. Patients with no contraindication for vaginal delivery (placenta previa, vasa previa, active genital herpes)\n9. Patients with no contraindications for mifepristone (chronic adrenal failure, concurrent long-term corticosteroid therapy, history of allergy to mifepristone, or other prostaglandins, hemorrhagic disorders or concurrent anticoagulant therapy, inherited porphyria, or an intrauterine device (IUD) in place)\n10. Patients with a Bishop score \\<6 at time of randomization\n11. Transcervical balloon in place \\<3 hours prior to the time of randomization without prior cervical preparation\n\nExclusion Criteria:\n\n1. Significant cardiac, renal, or hepatic maternal comorbidities, severe gestational hypertension or preeclampsia with severe features\n2. Pregnancies complicated by major fetal anomalies\n3. Patients with a uterine scar\n4. Pregnancies complicated by fetal growth restriction (Estimated fetal weight \\<10%)\n5. Pregnancies complicated by oligohydramnios\n6. Fetuses with an estimated fetal weight \\>4500 gm by recent ultrasound or Leopold's exam on admission\n7. Patients with class 3 obesity (BMI \\>40)\n8. Fetuses with a persistent category 2 or 3 fetal heart tracing at labor induction admission\n9. Vaginal bleeding at the time of randomization\n10. Any indication for scheduled cesarean delivery\n11. Hypersensitivity to oxytocin\n12. Uterine contractions equal to or greater than 5 in 10 minutes for sustained 30 minutes\n13. Hypersensitivity to prostaglandins","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"45 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Uterine Contractions","description":"Measured total number of uterine contractions per hour - with and without fetal heart rate decelerations.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"103","spread":null},{"groupId":"OG001","value":"112","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"15","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Uterine Tachysystole","description":"Participants with uterine tachysystole (more than 5 contractions in 10 minutes with and without fetal heart rate decelerations) .","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Minutes in Hypertonus","description":"Time in hypertonus (a single contraction lasting more than 2 minutes) per hour.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.33","spread":"5.16"},{"groupId":"OG001","value":"0.93","spread":"2.49"}]}]}]},{"type":"PRIMARY","title":"Time to Complete Cervical Dilation","description":"Total time from start of labor induction to complete cervical dilation (10 cm).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.0","spread":null},{"groupId":"OG001","value":"16.0","spread":null}]}]}]},{"type":"PRIMARY","title":"Time to Delivery","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26.0","spread":null},{"groupId":"OG001","value":"19.0","spread":null}]}]}]},{"type":"PRIMARY","title":"Total Labor and Delivery Unit Admission Duration Time","description":"Total time on Labor \\& Delivery from the time of admission to the time of transfer to postpartum unit","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29.0","spread":null},{"groupId":"OG001","value":"21.0","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Patients Who Undergo Cesarean Delivery","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Patients Able to Achieve Active Labor","description":"Active labor defined as cervical of dilation \\>=6 cm.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"13","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Patients With Severe Maternal Morbidity","description":"Number of participants with serious maternal morbidity based on CDC criteria for major maternal morbidity and mortality","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"PRIMARY","title":"Mean Neonatal Arterial Cord Blood pH","description":"Laboratory values for neonatal arterial cord blood pH. Arterial pH lower than 7.0 indicates metabolic acidosis.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.16","spread":"0.06"},{"groupId":"OG001","value":"7.17","spread":"0.06"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Neonatal APGAR Score <7","description":"Compare the APGAR scores (at 1 and 5 minutes). The Apgar score comprises five components: 1) color, 2) heart rate, 3) reflexes, 4) muscle tone, and 5) respiration, each of which is given a score of 0, 1, or 2; scores are summed for an overall score of 0 to 10 (higher scores reflect better neonatal outcomes).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Patients With Serious Neonatal Morbidity","description":"Defined as need for respiratory support within 72 hours after birth, hypoxic-ischemic encephalopathy, seizure, infection, meconium aspiration syndrome, intracranial or subgaleal hemorrhage, hypotension requiring vasopressor support, admission to neonatal intensive care unit","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":15},"commonTop":["5 min APGAR <7"]}}}